Literature DB >> 4964489

Severe pancytopenia associated with the use of intravesical thio-TEPA.

W E Watkins, J A Kozak, M J Flanagan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4964489     DOI： 10.1016/s0022-5347(17)62912-4

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

1.  Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder.

Authors:  M Csellár; A Csontai
Journal:  Int Urol Nephrol       Date:  1979       Impact factor: 2.370

2.  Absorption of drugs from the bladder and intravesical chemotherapy.

Authors:  M Pavone-Macaluso; N Gebbia
Journal:  Urol Res       Date:  1976-04-21

3.  Bladder hyperthermia in the treatment of vesical papillomatosis.

Authors:  G Lunglmayr; K Czech; F Zekert; G Kellner
Journal:  Int Urol Nephrol       Date:  1973-01       Impact factor: 2.370

Review 4.  The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer.

Authors:  Laura Douglass; Mark Schoenberg
Journal:  Bladder Cancer       Date:  2016-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.